SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-06
DOI
10.3389/fonc.2022.881801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
- (2022) Qun Cai et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
- (2021) Rangarirai Makuku et al. Journal of Immunology Research
- Multi-Omics Data Analysis of Gene Expressions and Alterations, Cancer-Associated Fibroblast and Immune Infiltrations, Reveals the Onco-Immune Prognostic Relevance of STAT3/CDK2/4/6 in Human Malignancies
- (2021) Bashir Lawal et al. Cancers
- Combination of UPLC–Q-TOF/MS and Network Pharmacology to Reveal the Mechanism of Qizhen Decoction in the Treatment of Colon Cancer
- (2021) Xianbin Kong et al. ACS Omega
- Emerging roles of suppressor of cytokine signaling 3 in human cancers
- (2021) Lirui Dai et al. BIOMEDICINE & PHARMACOTHERAPY
- Identification of immune-related genes and susceptible population of pulmonary tuberculosis by constructing TF-miRNA-mRNA regulatory network
- (2021) Quanquan Song et al. TUBERCULOSIS
- Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
- (2021) Xiaopei Hao et al. Frontiers in Cell and Developmental Biology
- Tumor Microenvironment
- (2020) Borros Arneth Medicina-Lithuania
- Large-scale public data reuse to model immunotherapy response and resistance
- (2020) Jingxin Fu et al. Genome Medicine
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway
- (2020) Mo Chen et al. Aging-US
- circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis
- (2019) Jian-Zhen Xu et al. Cell Death & Disease
- ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients
- (2019) János T. Fekete et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing microRNA‐221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling‐3‐dependent JAK/STAT pathway
- (2019) Chun‐Hua Xu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
- (2018) Jie Zhou et al. SEMINARS IN IMMUNOLOGY
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells
- (2018) Michihiro Yabe et al. Oncotarget
- Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically
- (2017) Chuandi Men et al. Journal of Gynecologic Oncology
- Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
- (2017) Collin M Blakely et al. NATURE GENETICS
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Monitoring immune responses in the tumor microenvironment
- (2016) Jennifer A Wargo et al. CURRENT OPINION IN IMMUNOLOGY
- Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis
- (2016) Li Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3
- (2015) JUN WAN et al. Molecular Medicine Reports
- jvenn: an interactive Venn diagram viewer
- (2014) Philippe Bardou et al. BMC BIOINFORMATICS
- DNA methylation profiles of long- and short-term glioblastoma survivors
- (2013) Thoraia Shinawi et al. Epigenetics
- Activation of the NF-κB Pathway by the STAT3 Inhibitor JSI-124 in Human Glioblastoma Cells
- (2013) Braden C. McFarland et al. MOLECULAR CANCER RESEARCH
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories
- (2013) Yan-gao Man et al. Journal of Cancer
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation
- (2011) Carina Lindemann et al. ACTA NEUROPATHOLOGICA
- GPS-Prot: A web-based visualization platform for integrating host-pathogen interaction data
- (2011) Marie E Fahey et al. BMC BIOINFORMATICS
- Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease
- (2009) Grace P. Yu et al. CLINICAL IMMUNOLOGY
- SOCS1 and SOCS3 in the control of CNS immunity
- (2009) Brandi J. Baker et al. TRENDS IN IMMUNOLOGY
- Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
- (2008) B. Sadikovic et al. CURRENT GENOMICS
- Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme
- (2008) Maurizio Martini et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started